Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.59
-0.09 (-1.35%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $698.76 million as of August 28, 2026. Its market cap has decreased by -5.14% in one year.
Market Cap
698.76M
Enterprise Value
627.38M
1-Year Change
-5.14%
Ranking
Category
Stock Price
$6.59
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $698.76M, an increase of 35.57%. That is a compound annual growth rate of 11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 698.76M | 8.89% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 729.17M |
| Bright Minds Biosciences | 721.39M |
| Shattuck Labs | 706.56M |
| Obsidian Therapeutics | 706.22M |
| BridgeBio Oncology Therapeutics | 700.72M |
| MapLight Therapeutics | 700.25M |
| CytomX Therapeutics | 699.46M |
| Allogene Therapeutics | 697.89M |